StockData
ALX Oncology Holdings Inc logo

ALX Oncology Holdings Inc (ALXO) stock

ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$1.06+0.04 (+3.92%)

Close on Nov 20, 2026Market cap $146.57MP/E –Yield –

ALX Oncology price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

ALX Oncology's price to sales ratio was 34.3× on Oct 30, 2020.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Oct 30, 202034.3×–

More ALX Oncology figures

See a number that looks wrong?